References
- Altrnan R. D., Honig S., Levin J. M., Lightfoot R. W. Ketoprofen versus indornethacin in patients with acute gouty arthritis. J. Rheumatol. 1988; 15: 1422–14261. Altrnan R. D., Honig S., Levin J. M., Lightfoot R. W. Ketoprofen versus indornethacin in patients with acute gouty arthritis. J. Rheumatol. 1988; 15: 1422–1426
- Berry H., Huskisson E. A trial of meprothixol. Clin. Trials J. 1972; 9: 13–152. Berry H., Huskisson E. A trial of meprothixol. Clin. Trials J. 1972; 9: 13–15
- Fava G., Galli L., Pollini C., Liverta C., Vicari A., Pontiroli A. E. Single nightly administration of ketoprofen and indomethacin suppositories in the management of osteoarthritis: a double-blind trial. J. Int. Med. Res. 1977; 5: 301–3073. Fava G., Galli L., Pollini C., Liverta C., Vicari A., Pontiroli A. E. Single nightly administration of ketoprofen and indomethacin suppositories in the management of osteoarthritis: a double-blind trial. J. Int. Med. Res. 1977; 5: 301–307
- Götzsche P. C. Patients' preference in indomethacin trials: an overview. Lancet 1989; 14: 88–914. Götzsche P. C. Patients' preference in indomethacin trials: an overview. Lancet 1989; 14: 88–91
- Jonderko G., Gabryel A., Galaszek Z., Dyczek-Paris E., Nowicki L., Szczesny-Siwinski H. Vergleichende crossover-doppelblind studie mit profenid und indometazin bei patienten mit rheumatoid-arthritis. Z. Gesamte. Inn. Med. 1982; 37: 242–2455. Jonderko G., Gabryel A., Galaszek Z., Dyczek-Paris E., Nowicki L., Szczesny-Siwinski H. Vergleichende crossover-doppelblind studie mit profenid und indometazin bei patienten mit rheumatoid-arthritis. Z. Gesamte. Inn. Med. 1982; 37: 242–245
- Ropes M. W., Bennett G. S. A., Cobb S., Jacox R., Jessar R. A. Revision of diagnostic criteria for rheumatoid arthritis. Bull. Rheum. Dis. 1958; 9: 1975–19766. Ropes M. W., Bennett G. S. A., Cobb S., Jacox R., Jessar R. A. Revision of diagnostic criteria for rheumatoid arthritis. Bull. Rheum. Dis. 1958; 9: 1975–1976
- Teule M. Double-blind comparative multicenter study of the efficacy and safety of a slow-release tablet of 200 mg ketoprofen once daily and a 50 mg ketoprofen capsule four times daily. Curs Thes Res. 1986; 40: 1129–11467. Teule M. Double-blind comparative multicenter study of the efficacy and safety of a slow-release tablet of 200 mg ketoprofen once daily and a 50 mg ketoprofen capsule four times daily. Curs Thes Res. 1986; 40: 1129–1146
- Thompson P. W. Articular indices of joint inflammation in rheumatoid arthritis. Correlation with the acute-phase response. Arthritis Rheum. 1987; 6: 618–6238. Thompson P. W. Articular indices of joint inflammation in rheumatoid arthritis. Correlation with the acute-phase response. Arthritis Rheum. 1987; 6: 618–623